Consonance Capital Management’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-2,568,684
| Closed | -$73.5M | – | 27 |
|
|
2015
Q4 | $73.5M | Sell |
2,568,684
-688,410
| -21% | -$19.7M | 9.86% | 2 |
|
|
2015
Q3 | $92.7M | Buy |
3,257,094
+273,000
| +9% | +$7.77M | 13.04% | 2 |
|
|
2015
Q2 | $107M | Buy |
2,984,094
+265,600
| +10% | +$9.54M | 10.77% | 2 |
|
|
2015
Q1 | $79M | Buy |
2,718,494
+210,000
| +8% | +$6.1M | 7.19% | 5 |
|
|
2014
Q4 | $52.9M | Buy |
2,508,494
+268,660
| +12% | +$5.66M | 6.81% | 6 |
|
|
2014
Q3 | $43.4M | Sell |
2,239,834
-136,798
| -6% | -$2.65M | 5.96% | 7 |
|
|
2014
Q2 | $37.1M | Buy |
2,376,632
+771,858
| +48% | +$12.1M | 5.52% | 7 |
|
|
2014
Q1 | $33.2M | Sell |
1,604,774
-488,515
| -23% | -$10.1M | 4.95% | 7 |
|
|
2013
Q4 | $27M | Buy |
2,093,289
+869,694
| +71% | +$11.2M | 4.43% | 8 |
|
|
2013
Q3 | $14.3M | Buy |
+1,223,595
| New | +$14.3M | 3.57% | 14 |
|